Two Sigma Advisers’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Two Sigma Advisers’s Portfolio RAIN Stock Details RAIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-157,100	Closed	-$189K	–	2707
2023 Q4	$189K	Sell	157,100 -59,800	-28%	-$64.5K	﹤0.01%	2245
2023 Q3	$187K	Buy	216,900 +95,400	+79%	+$105K	﹤0.01%	2111
2023 Q2	$146K	Buy	121,500 +92,700	+322%	+$464K	﹤0.01%	2155
2023 Q1	$252K	Buy	+28,800	New	+$266K	﹤0.01%	2202
2022 Q2	–	Sell	-13,500	Closed	-$68K	–	2945
2022 Q1	$68K	Buy	+13,500	New	+$108K	﹤0.01%	2555

Two Sigma Advisers's RAIN Position: Q1 2024 in Review

Two Sigma Advisers sold out of Rain Oncology Inc. Common Stock (RAIN) in Q1 2024, closing a stake of 157,100 shares — an estimated $189K sold.

Two Sigma Advisers first reported a position in RAIN in Q1 2022 and held it in 5 quarters. The position peaked at $252K in Q1 2023. 0 funds tracked by Wall St. Rank hold RAIN as of Q1 2024.

Two Sigma Advisers reported no remaining Rain Oncology Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Two Sigma Advisers sold 157,100 Rain Oncology Inc. Common Stock shares in Q1 2024, an estimated $189K.
Two Sigma Advisers first reported a position in Rain Oncology Inc. Common Stock in Q1 2022 and held it in 5 quarters.
Two Sigma Advisers's Rain Oncology Inc. Common Stock position peaked at $252K in Q1 2023.
0 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q1 2024.

Based on Two Sigma Advisers's 13F filing for Q1 2024, filed 15 May 2024.